In a 2013 publication, Gill et.al. sought to examine two things: the patterns of utilization of hypothermic machine perfusion (HMP) as a function of cold ischemic time (CIT) and donor type as well as the impact of HMP on the risk of DGF by CIT and donor type. They used data from the Scientific Registry of Transplant Recipients (SRTR) on all adult deceased donor kidney transplant recipients between January 1, 2000 and December 1, 2011 to complete their analysis.
The overall results of the analysis were:
- In standard criteria donors (SCD)
- The odds of DGF were lower with HMP compared to CS at all CIT
- In extended criteria donors (ECD)
- HMP use was associated with reduced risk of DGF when CIT is beyond 6 hours
- In donation after circulatory death (DCD) donors
- HMP use was associated with reduced risk of DGF when the CIT is between 6 and 24 hours
They summarized that their data confirmed the benefits of HMP use in reducing the risk of DGF irrespective of the donor type and CIT. They concluded that the best strategy to reduce the risk of DGF if to use HMP and minimize CIT in all deceased donor kidney transplants.
Read the full article here: https://doi.org/10.1097/01.tp.0000438637.29214.10
Check out the most recent posts
Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model
In a pre-clinical study using a porcine DCD model, Panayotova et al. sought to validate the novel technique of oxygen “pre-charge” for hypothermic machine perfusion (HMP) using the LifePort Liver Transporter. The study evaluated the effects of this preservation method...
David’s Transplant Journey
In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...
Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era
A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...
Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?
In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...